AI powers the future of pharmaceutical auditing: Qualifyze launches Quality Insights Platform to help the global pharmaceutical industry manage risk at its suppliers’ facilities
QUALIFYZE, the global leader in external audit services for the pharmaceutical industry, announces the launch of Quality Insights Platform , an AI-powered platform that transforms the world’s largest pharmaceutical audit database into a strategic risk management tool.
Supply chains stretched to the limit: Why the pharmaceutical industry can’t afford to wait
Ensuring the timely availability of medicines has become one of the greatest challenges facing the pharmaceutical industry today. While current tariffs on US imports have protected the pharmaceutical sector for now, the repercussions on the global economy are ongoing and are intensifying cost pressures. Furthermore, tightening regulatory frameworks, rising geopolitical tensions, and climate disruptions make the need for agile and proactive risk management at facilities undeniable.
Quality, Regulatory, and Procurement teams are under enormous pressure. When managing supplier data from multiple sources, many still rely on manual processes. This reactive approach creates costly quality incidents, regulatory setbacks, and reputational risks, not to mention operational stress for everyone involved.
Also Read: VantAI & Blueprint Expand Tie-Up on Proximity Drug Discovery
Introducing Quality Insights Platform: A smarter way to manage facility risk
Introducing the Quality Insights Platform: an AI-powered copilot for quality and procurement professionals. Based on Qualifyze’s proprietary data from over 4,500 audits, complemented by information from regulatory bodies, the platform provides actionable intelligence. It detects quality risks before they materialize and facilitates faster supplier qualification, strengthening supply chain resilience.
“This isn’t just an AI tool. Quality Insights adds an extra level of accuracy, as it’s based on our proprietary database of pharmaceutical audits—the largest in the world,” said Dr. Schneider, CEO of Qualifyze. “With this solution, we’re achieving at least a 65% reduction in time and costs for new supplier qualification and proactive quality risk management at plant sites.”
Almirall was one of the companies involved in developing the Quality Insights Platform. “The platform is intuitive and offers detailed and objective information. Having a common, easy-to-share data platform for sourcing discussions with the purchasing department is a real advantage,” said Miquel Romero , Senior Director of Quality Assurance at Almirall.
Source: PRNewswire
